K2 Principal Fund, L.P. Deep Medicine Acquisition Corp. Transaction History

K2 Principal Fund, L.P.

$210 Million
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 14, 2024	SELL	$0.25 - $0.35 $36,461 - $51,046	-145,847 Reduced 52.02%	134,514 $40,000
Q3 2023 Nov 13, 2023	BUY	$0.14 - $0.38 $15,929 - $43,236	113,779 Added 68.3%	280,361 $98,000
Q2 2023 Aug 14, 2023	SELL	$0.11 - $0.22 $9,636 - $19,273	-87,608 Reduced 34.47%	166,582 $26,000
Q1 2023 May 11, 2023	SELL	$0.06 - $0.15 $6,060 - $15,150	-101,000 Reduced 28.44%	254,190 $38,000
Q4 2022 Feb 10, 2023	SELL	$0.04 - $0.09 $4,792 - $10,782	-119,810 Reduced 25.22%	355,190 $21,000
Q4 2021 Feb 11, 2022	BUY	$9.82 - $9.86 $4.66 Million - $4.68 Million	475,000 New	475,000 $152,000

Others Institutions Holding DMAQR

# of Institutions

1

Shares Held

47.6K

Call Options Held

0

Put Options Held

0

B. Riley Securities, Inc. Los Angeles, CA

47.6K
Shares

$11,899
0.0% of portfolio

About Deep Medicine Acquisition Corp.

Ticker DMAQR
Exchange NASDAQ
Sector ETFs
Industry ETFs
Description
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020...

More about DMAQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

News

Stay updated on K2 Principal Fund, L.P. with notifications on news.